Pegloticase 8 mg in 1 mL Injection
RxNorm 1011653
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1011653 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pegloticase 8 mg in 1 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
1 mL pegloticase 8 mg/ML Injection
(Atom ID: 12333498)
SYPrescribable
Synonym (SY):
Pegloticase (as uricase protein) 8 mg per 1 mL Injection
(Atom ID: 8258891)
PSNPrescribable
Prescribable Name (PSN):
Pegloticase 8 mg in 1 mL Injection
(Atom ID: 8258889)
SYPrescribable
Synonym (SY):
Pegloticase 8 mg per 1 mL Injection
(Atom ID: 8258888)
PTPrescribable
Designated preferred name (PT):
Pegloticase 8 mg/mL solution for injection
(Atom ID: 11437953)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely pegloticase 8 mg/1 mL conventional release solution for injection (clinical drug)
(Atom ID: 11440478)
Patient Education
Pegloticase Injection
Pegloticase injection is used to treat ongoing gout (sudden, severe pain, redness, and swelling in one or more joints caused by abnormally high levels of a substance called uric acid in the blood) in adults who cannot take or did not respond to other medications. Pegloticase injection is in a class of medications called PEGylated uric acid specific enzymes. It works by decreasing the amount of uric acid in the body. Pegloticase injection is used to prevent gout attacks but not to treat them once they occur.
[Learn More]
* Please review the disclaimer below.